Gismo Therapeutics Inc. Receives Two Grants to Develop Novel Therapeutics for Parkinson’s Disease
Biotech Startup Receives More Funds to Advance its Drug Discovery Program LEXINGTON, Ky. and QUEENS, N.Y. (Oct. 12, 2017) – Gismo Therapeutics Inc. has been awarded two grants to continue its development of therapies to treat Parkinson’s Disease. A $384,000 SBIR grant entitled "Glycosaminoglycan-Interacting Small Molecule (GISMO) as Parkinson's Therapeutic" was awarded by the National [...]